跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector - TGA Drug Approval Details
Approvals
/
TGA
/
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector
Approved
STANDARD
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
67d226da54abd0bb
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
67d226da54abd0bb
Product Name
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector
Artg Id
296830
Artg Name
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2019-07-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/bcaf9507264461b63bca94a90d48a344.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
67d226da54abd0bb
Type
Standard
Back to TGA Approvals